Continuous Therapy with Nitroglycerin Impairs Endothelium-Dependent Vasodilation but Does Not Cause Tolerance in Conductance Arteries
- 1 November 2004
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Cardiovascular Pharmacology
- Vol. 44 (5), 601-606
- https://doi.org/10.1097/00005344-200411000-00014
Abstract
We investigated in healthy humans whether continuous therapy with organic nitrates impairs conduit artery responses to nitroglycerin (GTN) as well as its effects on endothelium-dependent vasodilation. Sixteen young male volunteers were randomized to continuous treatment with either transdermal GTN (0.6 mg/h/24 hrs for 6 days) or no therapy. Endothelium-dependent (flow-mediated) dilatation (FMD) and endothelium-independent (GTN-mediated) dilatation (GMD) of the brachial artery were evaluated before randomization (session 1), after six days of transdermal GTN treatment (session 2), and three hours after withdrawal of transdermal GTN (session 3). In the GTN group, on session 1, 0.4 mg sublingual GTN increased resting brachial artery diameter from 0.40 +/- 0.03 to 0.45 +/- 0.03 cm (P < 0.01). At the time of session 2, this GTN-mediated vasodilation remained unchanged at baseline (0.47 +/- 0.04 cm), with no further significant dilatation in response to either stimulus. On session 3, three hours after patch removal, baseline brachial artery diameter and GMD returned to pretreatment values, but FMD remained blunted (session 1: 8.7 +/- 2.5; session 3: 4.1 +/- 1.7%, P < 0.05). There was no change in these variables in the control group. Our data demonstrate that continuous GTN therapy impairs endothelium-dependent vasodilation in conduit arteries yet does not induce nitrate tolerance.Keywords
This publication has 26 references indexed in Scilit:
- Noninvasive assessment of nitrate tolerance using mitral Doppler and brachial artery ultrasonographyThe American Journal of Cardiology, 2003
- Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment.Circulation, 2002
- Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humansJournal of the American College of Cardiology, 2001
- Tetrahydrobiopterin improves endothelium-dependent vasodilation in nitroglycerin-tolerant ratsEuropean Journal of Pharmacology, 2001
- Nitroglycerin Tolerance in Human VesselsCirculation, 2000
- Nitrate Therapy for Stable Angina PectorisNew England Journal of Medicine, 1998
- Unexpected, Tolerance-Devoid Vasomotor and Platelet Actions of Pentaerythrityl TetranitrateJournal of Cardiovascular Pharmacology, 1997
- Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery diseaseJournal of the American College of Cardiology, 1996
- Absence of vascular tolerance in conductance vessels after 48 hours of intravenous nitroglycerin in patients with coronary artery diseaseJournal of the American College of Cardiology, 1995
- Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist.Circulation, 1989